Midatech Platforms Will Drive Specialty Pharma Share Of Voice
Executive Summary
Specialty pharma has been one of the hottest growth areas in recent years but with many companies entering into the space it is now a crowded marketplace. Speaking at Biotech Showcase 2018, Midatech Pharma CEO Jim Phillips told Scrip how the company’s three proprietary drug delivery platforms will underpin its ambitions to gain share of voice in the US and beyond, while outlining the prospects for its current pipeline.